Vaxcyte (NASDAQ:PCVX) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
2 weeks ago • Google News
Vaxcyte Inc (PCVX)
US$ 85.91-1.34%
Price Chart
Key Statistics
Market Cap
$ 4.44B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
223.23K
52W High
$ 121.06
52W Low
$ 27.66
Dividend Yield
0.00%
Beta
1.26
Technicals
50-Day MA
59.7896
200-Day MA
85.3294
52 Week High
121.055
52 Week Low
27.66
About PCVX
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
Employees
414
Headquarters
San Carlos, CA
CEO
Mr. Grant E. Pickering M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg